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ABSTRACT
Active promoters generally contain histone H3/H4
hyperacetylation and tri-methylation at H3 lysine 4,
whereas repressed promoters are associated with
DNA methylation. Here we show that the repressed
erythroid-specific carbonic anhydrase II (CAII) pro-
moter has active histone modifications localized
around the transcription start, while high levels of
CpG methylation are present directly upstream from
these active marks. Despite the presence of active
histone modifications, the repressed promoter
requires hormone-induced activation for efficient
preinitiation complex assembly. Transient and posi-
tional changes in histone H3/H4 acetylation and
local changes in nucleosome density are evident
during activation, but the bipartite epigenetic code
is stably maintained. Our results suggest that active
histone modifications may prevent spreading of
CpG methylation towards the promoter and show
that repressive DNA methylation immediately adja-
cent to a promoter does not necessarily repress
transcription.
INTRODUCTION
Chromatin is the physiologically relevant substrate for all
genetic processes in eukaryotic cells. It represents a signal
transduction platform for extracellular or intracellular signals
and regulates all genome functions. While DNMTs methylate
DNA, histone-acetyltransferases, histone-deacetylases, histone-
methyltransferases and histone-demethylases determine the
acetylation and methylation state of histones, the key protein
component of chromatin. The specific combinations of resulting
(post-translational) modifications are thought to provide tran-
sient or heritable epigenetic patterns that specify genome func-
tion. Emerging evidence causally links epigenetic alterations
of chromatin to a disturbed proliferation–differentiation bal-
ance implicated in many diseases, providing the rational for
the development of epigenetic treatment strategies using
DNA-demethylating agents and HDAC inhibitors (1,2).
Several studies have identified the presence of acetylated
histones H3/H4 and tri-methylated histone H3 lysine 4
(H3K4me3) co-localizing at 50 regions of active genes, sug-
gesting that these marks together represent an active code
(3–9). However, the identification of these marks also at inac-
tive genes suggests that the presence of these marks does not
necessarily correlate ongoing transcription per se (10,11), and
may as well represent a poised state.
Methylation of promoter CpG islands has been conceptually
linked to gene silencing (12–14). Importantly, methylation
seems to function as the dominant event that seals transcrip-
tional repression. Methyl DNA-binding (MBD) proteins such
as MeCP2 and MBD2 are known to be part of co-repressor
complexes that specifically associate with methylated CpGs,
contain HDAC activity and establish a repressive chromatin
configuration (13,15–18).
We have previously shown that the erythroid-specific car-
bonic anhydrase II (CAII) is silenced through the action of
the NCoR–SMRT co-repressor complex containing HDAC3
at an intronic enhancer and through a MeCP2–Sin3B co-
repressor complex containing HDAC2 at the CAII promoter
(19). Despite the presence of multiple HDAC-containing
co-repressor complexes, the silenced CAII promoter was
shown to be hyperacetylated. Here we have studied the epige-
netic code in detail and show that it consists of H3/H4 acety-
lation as well as high levels of H3K4me3 around and
downstream of the transcription start site. However, efficient
preinitiation complex assembly takes place only after ligand-
induced transcriptional activation of the promoter, and is
accompanied by transient and positional changes in acetyla-
tion and local nucleosome density. Interestingly, while the
upstream part of the CpG island is highly DNA-methylated,
the region of the CpG island carrying active histone marks
is maintained DNA methylation-free. This bipartite epigenetic
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code is largely unaffected by transcriptional activation of the
promoter, implying that localized DNA methylation—even
when adjacent to the transcription start site—is not
necessarily a hallmark of gene silencing.
MATERIALS AND METHODS
Cell culture
HD3 and HD3-V3 cells were cultured in S13 medium con-
sisting of Iscove’s Modified Dulbecco’s Medium (IMDM)
supplemented with 10% fetal calf serum, 2% chicken
serum, 0.7% BSA, 0.2% NaHCO3, 120 mg/ml tranferrine
(conalbumine), 110 mM b-mercaptoethanol. Before T3-
treatment, HD3-V3 cells were cultured for 48 h in medium
containing serum stripped by anion-ion exchange using AG
1-X8 resin (Bio-Rad). T3 was added to the medium to a
final concentration of 500 nM where indicated. For AZAdC
treatment cells were cultured for 5 days in the presence of
500 nM AZAdC. T2EC cells were cultured as described
previously (20).
Chromatin immunoprecipitations
ChIP experiments were performed at least three times using
independent chromatin preparations. Histone modification
ChIPs and reChIPs were performed exactly as described
previously (11). DNA recovered from ChIP was subjected
to quantitative real-time PCR using iQ SYBR Supermix
and a single-color detection MyIQ iCycler (Bio-Rad, Hercu-
les, CA, USA). The following formula was calculated
using [%ChIP/input] ¼ [E(CtinputCtChIP) * 100%], where E
represents the primer efficiency, as determined for every
primerset.
Mononucleosomal chromatin was prepared by the same
cross-linking procedure. Cells were washed once with PBS,
once with 5 ml NP-40 lysisbuffer (10 mM Tris, pH 7.4,
10 mM NaCl, 3 mM MgCl2 and 0.5% NP-40), once with
2.5 ml of micrococcal nuclease (MNase) digestion buffer
(10 mM Tris, pH 7.4, 15 mM NaCl and 60 mM KCl), and
resuspended in 1 ml of the same buffer with 1 mM CaCl2
at room temperature. MNase (200 units; Worthington) was
added and chromatin was digested to mononucleosomal
size for 30 min at room temperature. The digestion was
stopped by the addition of 1 ml stop buffer (100 mM Tris,
pH 8.0, 20 mM EDTA, 2% SDS and protease inhibitors).
After centrifuging for 10 min at room temperature the result-
ing supernatant was used for reChIP experiments.
For transcription factor ChIPs the following protocol was
used. Cells were collected and adjusted to 5 · 106 cells/ml
in culture medium. Cross-linking was done by adding
0.1 volof buffer A (50 mM HEPES, pH 7.6, 100 mM NaCl,
1 mM EDTA, 0.5 mM EGTA and 11% formaldehyde) and
incubated at room temperature for 30 min. Cross-linking
was stopped by the addition of glycine to a final concentra-
tion of 125 mM and incubation for 5 min at room tempera-
ture. Cells were washed once with ice-cold PBS, once with
buffer B (20 mM HEPES, pH 7.6, 0.25% Triton X-100,
10 mM EDTA and 0.5 mM EGTA), and once with buffer
C (50 mM HEPES, pH 7.6, 150 mM NaCl, 1 mM EDTA
and 0.5 mM EGTA). Washings consisted of a 10 min rotation
and a 7 min spin at 500 g (1200 r.p.m.) at 4C. The obtained
nuclei were resuspended in buffer D (20 mM HEPES, pH 7.6,
1 mM EDTA, 0.5 mM EGTA, protease inhibitors and 0.05%
SDS added freshly) to 20 · 106 nuclei/ml and sonicated
11 times for 10 s on ice-ethanol. The sonicated chromatin
was centrifuged for 5 min at 14 000000 g at 4C. The super-
natant was used directly for ChIP or stored at 80C. In a
final volume of 300 ml, 100 ml of chromatin was mixed
with, 60 ml of 5· incubation buffer (50 mM Tris–HCl,
pH 8.0, 750 mM NaCl, 5 mM EDTA, 2.5 mM EGTA, 5%
Triton X-100 and 0.75% SDS), 6 ml of 5% BSA, protease
inhibitors and 30 ml of 33% Protein A/G–agarose slurry.
Before use Protein A/G–agarose beads were washed twice
with 1· incubation buffer, 0.1% BSA twice for at least 2 h
at 4C. After preclearing for 2 h at 4C the supernatant was
collected, the appropriate antibody and 30 ml of 33% Protein
A/G–agarose slurry were added and samples were rotated
overnight at 4C. Protein A–agarose beads containing the
immune complexes were washed twice with wash buffer
1 (10 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA,
0.5 mM EGTA, 1% Triton X-100, 0.1% SDS, 0.1% DOC
and protease inhibitors), once with buffer 2 (as buffer 1,
but with 500 mM NaCl), once with buffer 3 (10 mM Tris–
HCl, pH 8.0, 1 mM EDTA, 0.5 mM EGTA, 0.5% DOC,
0.5% NP-40, 250 mM LiCl and protease inhibitors), and
twice with buffer 4 (10 mM Tris–HCl, pH 8.0, 1 mM
EDTA, 0.5 mM EGTA and protease inhibitors). Subsequent
elution, DNA purification and PCR analysis were performed
as for histone modification ChIPs described above.
Antibodies. The following antibodies were used: 2 mg of
anti-H3K9ac or anti-H4ac (Upstate #06-942 or #06-866,
respectively); 1 mg of anti-H3K4me1, anti-H3K4me2, anti-
H3K4me3 and anti-histone H3 (Abcam ab8895, ab7766,
ab8580 and ab1791, respectively); 2 mg of anti-H3K9me3
[#4861 (21) a gift from T. Jenuwein], 2 mg of anti-TBP,
10 mg of anti-TFIIA, 6 mg of anti-TFIIB, 6 mg of anti-RNAPII-
CTDser5-P and 2 mg of anti-RNAPII-CTD.
Oligonucleotides
The following oligonucleotides were used for quantitative
real-time PCR: NC3 (7 kb), 50-GCAGACACTGGCAGG-
TTTC-30; NC4 (7 kb), 50-TATGAGCCTTAGCCTTAG-30;
CT1 (4 kb), 50-CATGTAGTCAAGGTTGTT-30; CT2
(4 kb), 50-CTCATGGCATATCAGTGC-30; CAII 1.0 kb
A, 50-ACTCACAGTGGCCAGCAGAGTT-30; CAII 1.0kb
B, 50-CGGCGTTTTATCCCATCTTT-30; 5A (0.5 kb), 50-
CGGGAAAGCACACTCTCA-30; 6B (0.5 kb), 50-GGAAG-
GGATTAGCGGGGA-30; P16 (0 kb), 50-CGGAGAAGGGC-
ATGGAGTT-30; P18 (0 kb), 50-CCGGCTCCGTCGGCTA-
TC-30; CAII +0.5 kb A, 50-ATCGCCATCAGCACCAAAG-
30; CAII +0.5 kb B, 50-TGTCGGAGGAGTCGTCAAACT-30;
CAII +1.0 kb2 F, 50-TATGAGAACAGTTATAGGTATAG-30;
CAII +1.0 kb2 R, 50-TGTAATCCTCTGTTATTCTACAG-30;
CAII +6 kb F, 50-CAGCTGAGCTAAGAGCCACTTG-30;
CAII +6 kb R, 50-AGGTGTGAGTATGGCTGGGAA-30;
HS7 (+7 kb), 50-TCTGGAACATCCTTGCTA-30; 3P
(+7 kb), 50-AGCGGATGATGTAGAGAT-30; CAII 8 kb2 F,
50-ATGTGACTGCTGCCACTTCCT-30; CAII 8 kb2 R,
50-TCCCATGCAGAACAGGGC-30; GL6.241a (b-globin),
50-GGGTCCGACCAGGAAGGA-30; GL6.241b (b-globin),
50-TCAGTGCCAGGATTGAAGCA-30; 36882-F (b-globin),
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50-TGACACTGGAAACCTATGGCC-30; 36882-F (b-globin),
50-AGCCCCGAGTGCAGGTGGA-30; HinFI sat F, 50-CCC-
CACACGGACAAATTCA-30; HinFI sat R, 50-GAAATAC-
CTTACGCCCAGGAGA-30. For bisulphite sequencing three
PCR fragments encompassing the CAII promoter CpG island
were generated using nested PCR with the following primers:
CAII BSS5 F, 50-TYGGTGATGTTATTTTAGATTTATA-
GTGG-30; CAII BSS5 R, 50-CCCCTAATTCTTACTTAAAA-
ATATACTTTCC-30; CAII BSS6 F, 50-TAGAGTTYGGGT-
TAYGGGGTTG-30; CAII BSS6 R, 50-ATAAAACRATA-
CTCACRTTCACTCACC-30; CAII BSS8 F, 50-TYGTGGG-
AGTGGTGATTTAATTG-30; CAII BSS8 R, 50-CACCRCAT-
CACRCRAACTCCC-30; CAII BSS7 F, 50-YGYGYGTTTT-
TTATAAGGTGAGTG-30; CAII BSS7 R, 50-AAACRCTAC-
RACCTTAAACTAAAACAAC-30; CAII BSS1 F, 50-GAG-
TYGTTTTTAYGGTTTTTAGTAGGG-30; CAII BSS1 R, 50-
CRTACCCCCAATAATAAAACATAATAC-30; CAII BSS3
F, 50-TTYGTYGTYGTTGTTTTAGTTTAAGG-30; CAII BSS3
R, 50-CRTAACCTCRACRAACTATCAAAAAC-30.
Bisulphite sequencing
Less than 1 mg of sonicated genomic DNA was diluted to
50 ml in MQ. A small quantity measuring 5.7 ml of 3 M
NaOH was added and the samples were incubated at 37C
for 10 min. Thirty-three microliters of 16 mM hydroquinone
(freshly prepared) and 530 ml of 4 M sodium bisulphite solu-
tion (prepared by dissolving 3.8 g of Na2S2O5 in 7 ml of
MQ and adjusting the pH to 5.0 with 750 ml of 3 M
NaOH) was added and samples were incubated at 50C for
16–20 h. Samples were subsequently purified using QIAquick
PCR purification columns and eluted with 50 ml MQ at 50C.
After the addition of 5.7 ml of 3 M NaOH, samples were incu-
bated at 37C for 15–20 min and subsequently precipitated
using 17 ml of 10 M NH4Ac, 450 ml of 96% EtOH and
20 mg of glycogen. After washing with 70% EtOH DNA
was dissolved in 50 ml of MQ and used for PCR. The
obtained PCR fragments were cloned and for each fragment
10 clones were sequenced. Sequences were analyzed using
the MethTools program (22).
RESULTS
Locus-wide analysis of histone
modifications in HD3 cells
We previously showed that repression of the CAII promoter
correlates with the presence of the NCoR–HDAC3 co-
repressor complex at the HS2 intronic enhancer and the
MeCP2–Sin3–HDAC2 co-repressor at the promoter (see
Figure 1). Despite the presence of the HDAC-containing
co-repressor complex, the promoter is hyperacetylated (19).
To extend this observation and to study the epigenetic state
of the CAII locus in more detail we performed chromatin
immunoprecipitation (ChIP) analysis followed by real-time
PCR. We selected two upstream regions at 7 kb and at
4 kb known to be irrelevant to the regulation of CAII
expression, several regions throughout the CpG island pro-
moter from 1 to +1 kb, and around the downstream intronic
enhancer from +6 kb to +8 kb (see Figure 1).
First, histone H3 lysine 9 methylation (H3K9me3) was
analyzed. Although this mark has been extensively correlated
with repression, it has also been detected by others and us in
coding regions of active genes (11,23). Although an inverse
pattern compared with H3K4 tri-methylation seemed to be
present (Figure 2B), the overall levels of H3K9me3 were
only moderate. Whereas a positive control region for
H3K9me3 (HinFI satellites) showed 30% recovery, posi-
tions within the CAII locus showed only 5–10% recovery.
The b-globin 36 882 position has been described as con-
densed (H3K9-dimethylated) (24), but at this position we
found H3K9me3 to be as low as within the CAII locus.
Next, we analyzed methylation of histone H3 at lysine
4 (H3K4, Figure 2B) that can be either mono-, di- or tri-
methylated. High levels of H3K4-tri methylation were
observed at 0 kb and +1 kb (note the difference in the scale
used in Figure 2A–C). Lower levels were observed for H3K4
di-methylation at 0 kb. H3K4 mono-methylation was absent
at the promoter. Except for H3K4 mono methylation, levels
at the CAII promoter were considerably higher than at the
b-globin hyperacetylated/H3K4-dimethylated 6.241 position.
In addition to methylation, we analyzed acetylation that
correlates with active loci. As we have shown previously,
histones H3 and H4 were hyperacetylated at the promoter
(0 and +1 kb, Figure 2C) (19). Extending these analyses,
we now show that hyperacetylation is largely confined to
the promoter region, although the level at the promoter in
its silent state is lower when compared to the b-globin
6.241 position. Site-specific anti-acetylation antibodies
revealed that histone H3 was predominantly acetylated at
K9 whereas with histone H4, lysines 5, 8, 12 and 16 were
acetylated to the same extent (data not shown).
Altogether, these results corroborate and extend our previ-
ous analyses showing that the promoter contains localized
active histone modifications despite the presence of HDAC-
containing co-repressor complexes recruited to the promoter
and enhancer (19).
Histone modification changes during hormone-induced
activation of CAII expression
As the results described above showed that active histone
marks are already established under non-induced conditions,
we set out to assess whether the histone modification pattern
changes upon thyroid hormone-induced activation of CAII
expression. We have previously shown that the expression of
Figure 1. The carbonic anhydrase II (CAII) locus. Black bars, amplicons
used in ChIP experiments; gray bar, CpG island; open box, HS2 DNase I
hypersensitive site identified previously (26). HS2 is an intronic enhancer that
contains the v-ErbA response element. Positions relative to the transcription
start are indicated. The structure of the CAII gene is outlined at the bottom
with exons displayed as filled boxes.
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the CAII gene can be activated by T3 (thyroid hormone) in
HD3-V3 cells, which are complemented with a hormone
responsive gag-c-ErbA allele (25). This activation involved
dissociation of the NCoR–HDAC3 co-repressor complex
from the HS2 enhancer and replacement by a TRAP220-
containing co-activator complex, whereas the MeCP2-targeted
co-repressor complex remained bound to the CpG island at the
promoter (19). To study the timing of this activation, we iso-
lated total RNA from T3-induced HD3-V3 cells and analyzed
CAII transcription using real-time RT–PCR and intronic pri-
mers to directly measure transcriptional activity. Induction
was observed already after 5 min, with near-maximal induc-
tion after 30–60 min (Figure 3A).
Samples from this time-course experiment were used for
histone code ChIP analysis. Since it was evident from
Figure 2 that histone modifications associated with active
chromatin are predominantly targeted to sequences surround-
ing the transcription start, we increased the resolution of our
analysis within this region (1 to +1 kb), which encompasses
the complete CpG island, the transcription start site and part
of the first intron (see Figure 1).
H3K9me3 levels within the upstream intergenic and pro-
moter region remained constant over time (Figure 3B). How-
ever, downstream from the promoter H3K9me3 increased
gradually upon induction. Clearly, H3K9me3 within the active
CAII coding region is indicative of active rather then inactive
chromatin. This observation confirms previous observations
by others and us which showed H3K9me3 to be associated
with transcription elongation (11,23). At the +7 HS2 enhancer
position H3K9me3 did not increase. However, this position
appears to be rather nucleosome-poor (see below and
Figure 3F).
Figure 2. Analysis of histone modifications within the repressed CAII locus in HD3 cells. (A) Histone H3K9me3; ab; no antibody control. (B) Histone
H3K4me1, H3K4me2 and H3K4me3. (C) Histone H3K9ac and H4ac (K5, K8, K12, K16). Positions relative to the transcription start are indicated. 6241 is a
hyperacetylated/H3K4-dimethylated site and 36 882 is a H3K9-dimethylated site in the chicken b-globin locus, respectively, as described by Litt et al. (24).
HinFI sat, CR1-containing pericentromeric repeat element (32).
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Changes in histone modification patterns associated with
active chromatin remained restricted to the region surrounding
the transcription start (Figure 3C–E) except for H4 acetylation
that was also increased at gene internal positions upon gene
expression (Figure 3D). Quantitative and positional changes
were evident. H3K9 acetylation was highest at 0 kb in the
absence of T3 (Figure 3C). At this position, a decrease of
2-fold was apparent upon ligand induction. This decrease
Figure 3. ChIP analysis of histone modifications upon hormone-induced activation of CAII transcription. (A) CAII transcription upon addition of T3 was
quantified by real-time RT–PCR. An intronic primerset was used to monitor transcriptional activity. (B) Histone H3K9me3; (C) histone H3K9ac; (D) histone
H4ac (K5, K8, K12, K16); (E) histone H3K4me3; and (F) histone H3 (C-terminus). Positions relative to the transcription start are indicated.
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was mirrored by a gradual increase of 4-fold at the +1 kb
position. Throughout induction, the highest levels of H4
acetylation remained at the transcriptional start site; posi-
tional changes as observed for H3K9 acetylation were not
detected. H3K4 tri-methylation was found to be highest
around the transcription start site and decreased upon
ligand-induction (Figure 3E). Using a pan-H3 antiserum
we monitored nucleosome density throughout the locus dur-
ing T3-induction (Figure 3F). Constant levels of H3 were
measured at most positions, although slightly higher values
were present at 7, 4, +6 and +8 kb. At the transcriptional
start the initial level was similar to surrounding positions but
decreased gradually over time during induction, suggesting
nucleosome disruption or eviction. This could explain why
H3/H4ac and H3K4me3 locally decrease during induction,
and it implicates that the initial increase in H4 acetylation
is even more pronounced. At +7 kb H3 was initially low
and slightly decreased further during induction. This posi-
tion was previously identified as the HS2 DNase I hypersen-
sitive site (26). Whereas high levels of the active histone
modifications were present around and downstream from
the transcription start site, the upstream regions including
the distal region of the CpG island were almost devoid of
these modifications. At 1 kb H3K4 tri-methylation and
H3K9 acetylation were, respectively, 6-fold and 20-fold
lower than measured at the transcriptional start site, and,
respectively, 3-fold and 7-fold lower than at +1 kb. Since
the resolution of our ChIP experiments is not >500 bp
(the average DNA length of the chromatin used), it is pos-
sible that this transition is sharper than evident from
Figure 3. The presence of this transition suggests that
spreading of the active histone modifications in the upstream
direction is actively prevented or alternatively that modify-
ing enzymes are highly specifically targeted to the transcrip-
tion start site. Finally, H3K4 mono- and di-methylation
remained as low as in the repressed state (Figure 2 and
data not shown), and a conversion from H3K4 di- to tri-
methylation was not observed, as reported upon activation
in yeast (3).
Taken together, H3K9 tri-methylation is unaffected within
the upstream and promoter region upon activation, but is
increased within the gene-coding region. H3/H4 acetylation
and H3K4 tri-methylation co-localize over the transcriptional
start site and immediate downstream region. Remarkably, the
ligand-induced changes in the active code are not syn-
chronous but appear to follow their own individual dynamics,
while a modest but significant local nucleosome disruption or
eviction is evident. The active histone modifications are
absent at the distal part of the CpG island and beyond.
H3K9 acetylation, but not H3K9 tri-methylation, is
simultaneously present on H3K4 tri-methylated
nucleosomes
The results described above show that the active histone
code—H3/H4 acetylation and H3K4 tri-methylation—may
be confined to a few nucleosomes surrounding the transcrip-
tional start site. In addition, moderate levels of H3K9 tri-
methylation are present within the same region. To determine
whether these marks are targeted to the same or distinct
nucleosomes we performed consecutive ChIP experiments
(reChIPs) on cross-linked mononucleosomal chromatin.
After formaldehyde fixation of HD3 cells, mononucleosomal-
sized chromatin was prepared using MNase digestion (see
Figure 4A), subjected to a first-round ChIP, eluted and sub-
jected to a second-round ChIP. As expected, a first-round
ChIP using anti-H3K9ac or anti-H3K9me3 revealed that the
7.0 position contained H3K9me3 but low H3K9ac, while
the 0.0 position contained H3K9me3 and high H3K9ac
(Figure 4B, lanes 1–3). It should be noted that the H3K9ac
ChIP with mononucleosomal chromatin was much more
efficient than when using sonicated chromatin.
Next, anti-H3K9ac and anti-H3K9me3 were used in the
first-round ChIP, followed by a second-round ChIP using
anti-H3K4me3 (Figure 4B, lanes 4–6). H3K4me3 could be
recovered only at the 0.0 position, and only after a first-
round ChIP using anti-H3K9ac. At 7.0, H3K4me3 could
not be recovered because this position was devoid of
H3K9ac. These results provide strong evidence for the simul-
taneous presence of H3K9ac and H3K4me3 at the 0.0 position,
and indicate that H3K9me3 and H3K4me3 (i.e. inactive and
active marks) are unlikely to be present within the same
nucleosomes. The detection of both H3K9me3 and
H3K4me3 at the same positions in Figures 1 and 3, may be
explained by the use of sonicated chromatin, which may con-
tain more than one differentially modified nucleosomes.
Preinitiation complex assembly
The maintenance of active histone marks even under re-
pressive conditions prompted us to determine whether the
active histone marks signals the presence of basal transcrip-
tion factors and/or a (partially) pre-assembled preinitiation
complex. Therefore we analyzed the association of general
transcription factors under repressed as well as activated
conditions (Figure 5). General transcription factors were not
associated with the inactive promoter, although a weak but
reproducible level of TBP was observed under these condi-
tions. The presence of a preinitiation complex (PIC) was
evident after T3-treatment: TBP, TFIIB and TFIIA were
detected at the transcription start, whereas RNAPII and
Figure 4. H3K9 acetylation and H3K4 tri-methylation are targeted to the
same nucleosomes at the CAII promoter. (A) Mononucleosomal chromatin
from HD3 cells. Lane 1, DNA marker; lane 2, micrococcal nuclease-digested
chromatin. (B) ReChIP experiments. Mononucleosomal HD3 chromatin was
subjected to a first-round ChIP, eluted and subjected to a second-round ChIP.
The antibodies used for first- and second-round ChIPs are indicated.
Recovered DNA was quantified using real-time PCR.
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CTD-Ser5-phosphorylated RNAPII could in addition be
detected at positions downstream from the transcription start,
indicative of ongoing transcription. Thus, despite the active
histone marks at the CAII promoter, full establishment of the
PIC occurs only upon T3-treatment.
DNA methylation is restricted to the distal
part of the CpG island
Our previous work indicated that the CpG island CAII
promoter in its repressed state is partially DNA methylated
and associated with a MeCP2–Sin3–HDAC2 co-repressor
complex (19). These data seemingly contradict our present
findings, since DNA hypermethylation of promoter-CpG
islands is conceptually related to silencing of genes and
heterochromatin formation, e.g. deacetylation of H3/H4 and
methylation of H3K9. This apparent contradiction prompted
us to reinvestigate in more detail the DNA methylation
pattern at the CpG island containing the CAII promoter.
The CpG island is located from 1100 to +700 bp relative
to the transcription start site (Figure 1). Although the
upstream part of this CpG island (1100 to 600) has a
lower GC-content and observed/expected CpG ratio (56%
and 0.8, respectively) than the downstream part (600 to
+700, 74% and 1.1, respectively), the upstream part still
meets the criteria of a CpG island [>200 bp in length,
>50% GC and observed/expected CpGs >0.6 (27)]. Chicken
CpG islands have higher GC-contents than those of mouse
and human, but the upstream part or the CAII CpG island
has 58% GC, which is well above the average of chromosome
2 [40% (28)]. Bisulphite sequencing showed that CpG
hypermethylation was present within this upstream region
of the CpG island (66% at 1091 to 600, Figure 6A).
Remarkably, methylation was absent at the promoter-
proximal region of the CpG island (600 to 12), where
CpG density is highest. Thus, the epigenetic state of the
CpG island is bipartite: the upstream part is extensively
CpG methylated and lacks active histone modifications,
whereas the downstream promoter-proximal part is devoid
of DNA methylation and contains active histone modifica-
tions. We previously reported that the CAII CpG island is
associated with the MeCP2–Sin3–HDAC2 complex (19).
This association most likely takes place at the upstream,
methylated part. Notably, for ChIP analysis of MeCP2 a
primerset located around position 500 was used in those
experiments.
Next, we tested whether activation of transcription by T3
ligand caused loss of CpG methylation. Following induction,
methylation in upstream part of the CpG island was largely
maintained at 24 h after induction (55% CpG methylation,
Figure 6B and C). We previously demonstrated that the
DNA methylation inhibitor AZAdC causes (partial) dislodge-
ment of MeCP2–Sin3 co-repressor complex and activation of
CAII expression [Figure 7A and (19)]. We therefore tested
whether an AZAdC-induced loss of CpG methylation
would cause a concomitant increase in histone acetylation
in the upstream part of the CpG island promoter. AZAdC
treatment over a period of 5 days resulted in more than
6-fold increase of CAII gene expression (Figure 7A), and
extensive loss of CpG methylation (from 66 to 18%),
although some cells within the analyzed population appeared
to have partially retained CpG methylation (Figure 6D). The
same samples were used to analyze active histone modifica-
tions. The AZAdC treatment did not alter the position of
these modifications, although quantitative changes of individ-
ual modifications were evident (Figure 7B). Whereas H4ac
decreased locally at the transcription start site, H3Ac and
H3K4me3 increased at all of the measured positions, with a
maximum of 2-fold. Thus, CpG demethylation does not
cause positional changes in the active histone marks, but
rather appears to consolidate levels of these modifications.
Active histone marks but not the DNA methylation
pattern is established in erythrocytic progenitor cells
The results described above showed that the bipartite epige-
netic code is present in cells in which CAII expression is not
induced, and persists during activation of gene expression.
Moreover, active histone marks are stably maintained even
when CpG methylation in the upstream part of the CpG
island is removed. To test whether the bipartite organization
of the described epigenetic pattern is already established earl-
ier during differentiation, we analyzed active histone modifi-
cations and the DNA methylation pattern in chicken T2EC
cells. These cells are very immature haematopoietic progeni-
tor cells committed to the erythrocytic lineage and should be
considered non-transformed (20).
The level of CAII expression in T2EC is about 9-fold
higher than in HD3 cells (repressed state) but 4-fold lower
than in T3-induced V3 cells (Figure 7A). Analysis of histone
modifications in T2EC cells showed that the H3K9me3 pat-
tern is essentially the same as in HD3 cells (Figure 8A).
Only the gene-coding region has elevated H3K9me3, which
is in agreement with the higher level of transcriptional
elongation in T2EC cells (see Figure 7A). Active histone
marks are also present in these cells, although peak levels
were concentrated to a more upstream position; at 0.5 kb
Figure 5. Assembly of the preinitiation complex at the CAII promoter. ChIP
analysis was performed on HD3 cells (white and light gray bars) and 24 h
T3-treated HD3-V3 cells (black and dark gray bars), in which CAII is
repressed or induced, respectively. Values are expressed as occupancy
relative to the 7 kb position. Positions relative to the transcription start site
are indicated.
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all modifications were higher than in HD3 cells or ligand-
induced V3 cells (compare Figure 8B and C with Figures 2
and 3). In addition, at +6 kb H4 acetylation was considerably
higher than in HD3 cells. A transient increase in H4ac at this
position was also evident during ligand induction of V3 cells
(see Figure 3C). Bisulphite sequencing analysis showed that
DNA methylation is largely absent in T2EC cells; only 5%
CpG methylation was measured in the upstream part of the
CpG island (Figure 6E). We also measured the association
of TBP with the CAII promoter. As expected for a (partially)
active promoter, TBP was enriched at the transcription start
(Figure 8D). Thus, earlier in differentiation under conditions
when the CAII promoter is not repressed through AEV trans-
formation, TBP is associated with the CAII promoter, active
histone modifications are established and CpG methylation
is absent.
DISCUSSION
In this study we characterized the epigenetic code of the CAII
locus and in particular its promoter (present within a CpG
island) under repressive conditions as well as upon hormone-
induced activation. Active histone modifications including
H3K9/H4 acetylation and H3K4 tri-methylation are present
already under repressive conditions and are localized almost
exclusively around the transcription start site. Sequential
ChIP experiments showed that these histone marks are prim-
arily present on the same nucleosomes, whereas H3K4me3-
containing nucleosomes seem to be devoid of the ubiqui-
tously present H3K9me3. Nevertheless, the individual active
marks follow their own individual pattern upon activation of
transcription. Within the upstream part of the CpG island
active histone modifications are absent and the DNA is hyper-
methylated. However, H3K9me3 is only slightly higher
within the hypermethylated region. DNA hypermethylation
is almost completely maintained upon activation of transcrip-
tion by T3 ligand. Even more strikingly, treatment with
AZAdC does not cause drastic changes in positioning of
the active histone marks, suggesting that DNA hypermethyla-
tion and the association of the previously reported MeCP2–
Sin3 complex are not the critical factors in establishing or
maintaining a chromatin boundary. The lack of DNA
methylation-spreading may instead be the consequence of a
Figure 6. The upstream part of the CAII promoter CpG island is methylated. Bisulphite sequencing analysis of CpG-methylation in (A) HD3 cells; (B) uninduced
V3 cells; (C) V3 cells after 24 h of T3 induction; (D) HD3 cells after 5 days of AZAdC treatment; and (E) T2EC erythrocytic progenitor cells. Genomic DNA
was treated as described, PCR-amplified and cloned for sequencing. Individual clones were sequenced. Closed circles, methylated CpG; open circles,
unmethylated CpG. Positions relative to the transcription start are indicated.
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boundary formed by local and high levels of active histone
marks. Indeed, chromatin boundaries between escape genes
and X-inactivated genes have been shown to contain high lev-
els of localized acetylation (29). Here, the zinc-finger protein
CTCF is involved in boundary formation, and it is possible
that CTCF also plays a role at the CAII locus.
Although H3K4 tri-methylation is generally regarded as an
indicator for active chromatin transcription, the level of
H3K4 tri-methylation level does not correlate with CAII pro-
moter activity, and its presence does not necessarily signal
ongoing transcription. We have made similar observations
for unexpressed genes at the human X-chromosome (11).
Moreover, H3K4 tri-methylation is not subjected to signifi-
cant alteration upon transcriptional activation, but instead is
high in both the repressive and active state. Next to marking
active chromatin, H3K4 tri-methylation may well mark pro-
moters that become activated and provide the epigenetic set-
ting to facilitate such future activation.
Our results show that PIC assembly is inhibited notwith-
standing the active histone modifications at the CAII pro-
moter. This indicates that the establishment of an active
epigenetic code alone is insufficient to establish productive
transcription. It seems likely that PIC assembly at the pro-
moter is critically regulated through communication with the
+7 kb HS2 enhancer which recruits the v-ErbA/NCoR-HDAC
complex during repression, and the TRAPP220 co-activator
upon activation (19).
Hormone-induced activation of CAII transcription is
associated with changes in H3/H4 acetylation, H3K4 tri-
methylation, but also nucleosome density, as measured
through the association of histone H3. At the transcriptional
start site, nucleosome depletion or eviction most likely
occurs. This explains why H3/H4ac and H3K4me3 locally
decrease during induction, and implicates that the levels of
H3K9-Ac and H3K4me3 themselves do not decrease but
are—at least partially—maintained. Furthermore, the initial
increase in H4 acetylation is in fact even more pronounced.
A lowered nucleosome density at the transcriptional start is
consistent with our previous observations that ligand induces
a DNase I hypersensitive site around the transcriptional start
site (26). Since the pan-H3 antiserum does not discriminate
between histone H3 and H3.3 histone replacement cannot
be excluded. At +7 kb H3 was initially low and slightly
decreased even further during T3-induction. This position
corresponds with the HS2 DNase I hypersensitive site
(19,26). The low levels of H3 measured at the HS2 enhancer
strongly suggest that this position is locally devoid of nucleo-
somes, and explain the low levels of all tested histone modi-
fications at this position (see Figures 2, 3 and 8).
Inhibition of DNA methylation by AZAdC results in mod-
est activation of CAII expression as compared to hormone-
induced activation (Figure 7A). Although a significant
decrease in CpG methylation is induced at the upstream
part of the CpG island (Figure 6D), AZAdC treatment does
not cause a positional change of the active histone marks.
Instead, a moderate local increase in H3K9 acetylation and
H3K4 tri-methylation is evident. The increase in H3K9 acety-
lation could be the result of the dislodgement of MeCP2-
complexed HDACs immediately upstream from the active
histone marks. Intrusion of the active epigenetic code into
the distal part of the CpG island does not occur, reinforcing
the notion of the presence of a boundary or an activity that
targets and maintains the active histone marks to a particular
position.
In the T2EC erythrocytic progenitor cells the CAII gene is
transcribed, the active histone marks are associated with the
CAII promoter, but DNA methylation is absent. DNA methy-
lation has apparently occurred later during differentiation,
although it is currently unclear whether this also occurs in
Figure 7. Analysis of active histone modifications after 5 days of AZAdC
treatment. (A) Comparison of CAII transcription levels under various
conditions by real-time RT–PCR using intronic primers. (B) Analysis of
active histone modification changes after AZAdC treatment. Positions
relative to the transcription start site are indicated.
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the animal or whether DNA methylation is due to AEV-
induced transformation and/or culturing. DNA methylation
has been postulated to be a secondary event that occurs
after initial silencing events involving other mechanisms
(12). A possible scenario for CAII repression would involve
the initial AEV-mediated delivery of a dominant negative
v-ErbA that is not responsive to T3. Although this subse-
quently repressed transcription by inhibiting PIC assembly,
it did not lead to histone deacetylation at the promoter. Sub-
sequently, DNA methylation evoked by this repressed state
could have progressed towards the CAII promoter, but halted
because of the presence of a putative boundary which may
involve the active histone marks in addition to other factors.
Such factors may include CTCF, which has been shown to
protect DNA against de novo DNA methylation during
imprinting (30), and the combinatorial presence of CTCF
and active histone modifications hints to the possibility that
they establish a chromatin state that does not permit DNA
methylation to spread.
We present here the first example of a bipartite CpG island
code, but such codes may be a general phenomenon. Similar
local CpG methylation patterns have been described for
promoter-containing CpG islands of the mouse and human
APRT, ADA and telomerase genes (31), but histone modifi-
cations have not been analyzed in these promoters. Whether a
bipartite CpG island code is linked to genes that are actively
Figure 8. Analysis of active histone modifications in T2EC erythrocytic progenitor cells. (A) Histone H3K9me3; (B) histone H3K4me1, H3K4me2 and
H3K4me3; and (C) histone H3/H4 acetylation. (D) ChIP analysis of TBP binding in T2EC cells. Values are expressed as occupancy relative to the 7 kb
position. Positions relative to the transcription start are indicated.
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repressed like CAII remains to be elucidated. Silencing by
CpG methylation is believed to involve progressive spreading
of DNA methylation, eventually covering entire CpG islands.
Our data suggest that boundary elements function as crucial
antagonists against such gene silencing events. Whatever
the molecular mechanism, the bipartite code within the
promoter does not preclude gene activity, and as such it chal-
lenges the paradigm that methylation of promoter-containing
CpG islands invariantly causes gene silencing.
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